About this Journal Submit a Manuscript Table of Contents
Stem Cells International
Volume 2011 (2011), Article ID 536758, 20 pages
http://dx.doi.org/10.4061/2011/536758
Review Article

Stem Cell Therapy in Acute Myocardial Infarction: A Pot of Gold or Pandora's Box

1Interventional Cardiologist, Sir H.N. Hospital and Research Centre, Raja Rammohan Roy Road, Mumbai 400 004, India
2Sir H.N. Medical Research Society, Sir H.N. Hospital and Research Centre, Raja Rammohan Roy Road, Mumbai 400 004, India

Received 1 September 2010; Revised 18 December 2010; Accepted 29 December 2010

Academic Editor: Shijun Hu

Copyright © 2011 V. K. Shah and K. K. Shalia. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. W. Stone, C. L. Grines, D. A. Cox et al., “Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction,” New England Journal of Medicine, vol. 346, no. 13, pp. 957–966, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. G. Montalescot, P. Barragan, O. Wittenberg et al., “Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction,” New England Journal of Medicine, vol. 344, no. 25, pp. 1895–1903, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. J. Kajstura, A. Leri, N. Finato, C. Di Loreto, C. A. Beltrami, and P. Anversa, “Myocyte proliferation in end-stage cardiac failure in humans,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 15, pp. 8801–8805, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. A. P. Beltrami, K. Urbanek, J. Kajstura et al., “Evidence that human cardiac myocytes divide after myocardial infarction,” New England Journal of Medicine, vol. 344, no. 23, pp. 1750–1757, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. A. M. Hierlihy, P. Seale, C. G. Lobe, M. A. Rudnicki, and L. A. Megeney, “The post-natal heart contains a myocardial stem cell population,” FEBS Letters, vol. 530, no. 1–3, pp. 239–243, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. M. A. Laflamme, D. Myerson, J. E. Saffitz, and C. E. Murry, “Evidence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts,” Circulation Research, vol. 90, no. 6, pp. 634–640, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. F. Quaini, K. Urbanek, A. P. Beltrami et al., “Chimerism of the transplanted heart,” New England Journal of Medicine, vol. 346, no. 1, pp. 5–15, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. K. A. Jackson, S. M. Majka, H. Wang et al., “Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells,” Journal of Clinical Investigation, vol. 107, no. 11, pp. 1395–1402, 2001. View at Scopus
  9. B. Bittira, D. Shum-Tim, A. Al-Khaldi, and R. C. J. Chiu, “Mobilization and homing of bone marrow stromal cells in myocardial infarction,” European Journal of Cardio-thoracic Surgery, vol. 24, no. 3, pp. 393–398, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Bayes-Genis, E. Muñiz-Diaz, L. Catasus et al., “Cardiac chimerism in recipients of peripheral-blood and bone marrow stem cells,” European Journal of Heart Failure, vol. 6, no. 4, pp. 399–402, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. A. A. Kocher, M. D. Schuster, M. J. Szabolcs et al., “Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function,” Nature Medicine, vol. 7, no. 4, pp. 430–436, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. T. C. Doetschman, H. Eistetter, M. Katz, W. Schmidt, and R. Kemler, “The in vitro development of blastocyst-derived embryonic stemcell lines: formation of visceral yolk sac, blood islands and myocardium,” Journal of Embryology and Experimental Morphology, vol. 87, pp. 27–45, 1985.
  13. J. S. Odorico, D. S. Kaufman, and J. A. Thomson, “Multilineage differentiation from human embryonic stem cell lines,” Stem Cells, vol. 19, no. 3, pp. 193–204, 2001. View at Scopus
  14. C. E. Murry and G. Keller, “Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development,” Cell, vol. 132, no. 4, pp. 661–680, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. I. Kehat, D. Kenyagin-Karsenti, M. Snir et al., “Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes,” Journal of Clinical Investigation, vol. 108, no. 3, pp. 407–414, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Snir, I. Kehat, A. Gepstein et al., “Assessment of the ultrastructural and proliferative properties of human embryonic stem cell-derived cardiomyocytes,” American Journal of Physiology, vol. 285, no. 6, pp. H2355–H2363, 2003. View at Scopus
  17. A. C. Fijnvandraat, A. C. G. Van Ginneken, C. A. Schumacher et al., “Cardiomyocytes purified from differentiated embryonic stem cells exhibit characteristics of early chamber myocardium,” Journal of Molecular and Cellular Cardiology, vol. 35, no. 12, pp. 1461–1472, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Behfar, L. V. Zingman, D. M. Hodgson et al., “Stem cell differentiation requires a paracrine pathway in the heart,” FASEB Journal, vol. 16, no. 12, pp. 1558–1566, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. M. G. Klug, M. H. Soonpaa, G. Y. Koh, and L. J. Field, “Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts,” Journal of Clinical Investigation, vol. 98, no. 1, pp. 216–224, 1996. View at Scopus
  20. J. Y. Min, Y. Yang, K. L. Converso et al., “Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats,” Journal of Applied Physiology, vol. 92, no. 1, pp. 288–296, 2002. View at Scopus
  21. D. Vittet, M. H. Prandini, R. Berthier et al., “Embryonic stem cells differentiate in vitro to endothelial cells through successive maturation steps,” Blood, vol. 88, no. 9, pp. 3424–3431, 1996. View at Scopus
  22. B. Blum and N. Benvenisty, “The tumorigenicity of human embryonic stem cells,” Advances in Cancer Research, vol. 100, pp. 133–158, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. J. S. Draper, C. Pigott, J. A. Thomson, and P. W. Andrews, “Surface antigens of human embryonic stem cells: changes upon differentiation in culture,” Journal of Anatomy, vol. 200, no. 3, pp. 249–258, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. H. S. Silverman and M. P. Pfeifer, “Relation between use of antiinflammatory agents and left ventricular free wall rupture during acute myocardial infarction,” American Journal of Cardiology, vol. 59, no. 4, pp. 363–364, 1987. View at Scopus
  25. K. Okita, T. Ichisaka, and S. Yamanaka, “Generation of germline-competent induced pluripotent stem cells,” Nature, vol. 448, no. 7151, pp. 313–317, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. K. Takahashi, K. Tanabe, M. Ohnuki et al., “Induction of pluripotent stem cells from adult human fibroblasts by defined factors,” Cell, vol. 131, no. 5, pp. 861–872, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. M. Wernig, A. Meissner, R. Foreman et al., “In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state,” Nature, vol. 448, no. 7151, pp. 318–324, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. K. Takahashi and S. Yamanaka, “Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors,” Cell, vol. 126, no. 4, pp. 663–676, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. R. Blelloch, M. Venere, J. Yen, and M. Ramalho-Santos, “Generation of induced pluripotent stem cells in the absence of drug selection,” Cell Stem Cell, vol. 1, no. 3, pp. 245–247, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. M. Wernig, A. Meissner, R. Foreman et al., “In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state,” Nature, vol. 448, no. 7151, pp. 318–324, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. S. I. Nishikawa, R. A. Goldstein, and C. R. Nierras, “The promise of human induced pluripotent stem cells for research and therapy,” Nature Reviews Molecular Cell Biology, vol. 9, no. 9, pp. 725–729, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. S. Yamanaka, “Strategies and new developments in the generation of patient-specific pluripotent stem cells,” Cell Stem Cell, vol. 1, no. 1, pp. 39–49, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. J. Yamashita, H. Itoh, M. Hirashima et al., “Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors,” Nature, vol. 408, no. 6808, pp. 92–96, 2000. View at Publisher · View at Google Scholar · View at PubMed
  34. S. Marchetti, C. Gimond, K. Iljin et al., “Endothelial cells genetically selected from differentiating mouse embryonic stem cells incorporate at sites of neovascularization in vivo,” Journal of Cell Science, vol. 115, no. 10, pp. 2075–2085, 2002.
  35. J. A. Thomson, J. Itskovitz-Eldor, S. S. Shapiro, et al., “Embryonic stem cell lines derived from human blastocysts,” Science, vol. 282, pp. 1145–1147, 1998.
  36. H. Mayani and P. M. Lansdorp, “Biology of human umbilical cord blood-derived hematopoietic stem/progenitor cells,” Stem Cells, vol. 16, no. 3, pp. 153–165, 1998.
  37. A. Erices, P. Conget, and J. J. Minguell, “Mesenchymal progenitor cells in human umbilical cord blood,” British Journal of Haematology, vol. 109, no. 1, pp. 235–242, 2000. View at Publisher · View at Google Scholar
  38. N. Ma, C. Stamm, A. Kaminski et al., “Human cord blood cells induce angiogenesis following myocardial infarction in NOD/scid-mice,” Cardiovascular Research, vol. 66, no. 1, pp. 45–54, 2005. View at Publisher · View at Google Scholar · View at PubMed
  39. M. S. Parmacek, “Cardiac stem cells and progenitors: developmental biology and therapeutic challenges,” Transactions of the American Clinical and Climatological Association, vol. 117, pp. 239–256, 2006.
  40. C. M. Martin, A. P. Meeson, S. M. Robertson et al., “Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart,” Developmental Biology, vol. 265, no. 1, pp. 262–275, 2004. View at Publisher · View at Google Scholar
  41. A. P. Beltrami, L. Barlucchi, D. Torella et al., “Adult cardiac stem cells are multipotent and support myocardial regeneration,” Cell, vol. 114, no. 6, pp. 763–776, 2003. View at Publisher · View at Google Scholar
  42. H. Oh, S. B. Bradfute, T. D. Gallardo et al., “Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 21, pp. 12313–12318, 2003. View at Publisher · View at Google Scholar · View at PubMed
  43. E. Messina, L. De Angelis, G. Frati et al., “Isolation and expansion of adult cardiac stem cells from human and murine heart,” Circulation Research, vol. 95, no. 9, pp. 911–921, 2004. View at Publisher · View at Google Scholar · View at PubMed
  44. K. Urbanek, M. Rota, S. Cascapera et al., “Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival,” Circulation Research, vol. 97, no. 7, pp. 663–673, 2005. View at Publisher · View at Google Scholar · View at PubMed
  45. O. Pfister, F. Mouquet, M. Jain et al., “CD31- but not CD31+ cardiac side population cells exhibit functional cardiomyogenic differentiation,” Circulation Research, vol. 97, no. 1, pp. 52–61, 2005. View at Publisher · View at Google Scholar · View at PubMed
  46. T. Oyama, T. Nagai, H. Wada et al., “Cardiac side population cells have a potential to migrate and differentiate into cardiomyocytes in vitro and in vivo,” Journal of Cell Biology, vol. 176, no. 3, pp. 329–341, 2007. View at Publisher · View at Google Scholar · View at PubMed
  47. F. Mouquet, O. Pfister, M. Jain et al., “Restoration of cardiac progenitor cells after myocardial infarction by self-proliferation and selective homing of bone marrow-derived stem cells,” Circulation Research, vol. 97, no. 11, pp. 1090–1092, 2005. View at Publisher · View at Google Scholar · View at PubMed
  48. B. Dawn, A. B. Stein, K. Urbanek et al., “Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 10, pp. 3766–3771, 2005. View at Publisher · View at Google Scholar · View at PubMed
  49. C. Bearzi, M. Rota, T. Hosoda et al., “Human cardiac stem cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 35, pp. 14068–14073, 2007. View at Publisher · View at Google Scholar · View at PubMed
  50. M. Rota, M. E. Padin-Iruegas, Y. U. Misao et al., “Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function,” Circulation Research, vol. 103, no. 1, pp. 107–116, 2008. View at Publisher · View at Google Scholar · View at PubMed
  51. R. R. Smith, L. Barile, H. C. Cho et al., “Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens,” Circulation, vol. 115, no. 7, pp. 896–908, 2007. View at Publisher · View at Google Scholar · View at PubMed
  52. P. Van Vliet, M. Roccio, A. M. Smits et al., “Progenitor cells isolated from the human heart: a potential cell source for regenerative therapy,” Netherlands Heart Journal, vol. 16, no. 5, pp. 163–169, 2008.
  53. N. Takehara, Y. Tsutsumi, K. Tateishi et al., “Controlled delivery of basic fibroblast growth factor promotes human cardiosphere-derived cell engraftment to enhance cardiac repair for chronic myocardial infarction,” Journal of the American College of Cardiology, vol. 52, no. 23, pp. 1858–1865, 2008. View at Publisher · View at Google Scholar · View at PubMed
  54. A. Linke, P. Müller, D. Nurzynska et al., “Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 25, pp. 8966–8971, 2005. View at Publisher · View at Google Scholar · View at PubMed
  55. X. Wang, Q. Hu, Y. Nakamura et al., “The role of the Sca-1/CD31 cardiac progenitor cell population in postinfarction left ventricular remodeling,” Stem Cells, vol. 24, no. 7, pp. 1779–1788, 2006. View at Publisher · View at Google Scholar · View at PubMed
  56. E. Fuchs, T. Tumbar, and G. Guasch, “Socializing with the neighbors: stem cells and their niche,” Cell, vol. 116, no. 6, pp. 769–778, 2004. View at Publisher · View at Google Scholar
  57. K. A. Moore and I. R. Lemischka, “Stem cells and their niches,” Science, vol. 311, no. 5769, pp. 1880–1885, 2006. View at Publisher · View at Google Scholar · View at PubMed
  58. K. Urbanek, D. Torella, F. Sheikh et al., “Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 24, pp. 8692–8697, 2005. View at Publisher · View at Google Scholar · View at PubMed
  59. D. Torella, G. M. Ellison, S. Méndez-Ferrer, B. Ibanez, and B. Nadal-Ginard, “Resident human cardiac stem cells: role in cardiac cellular homeostasis and potential for myocardial regeneration,” Nature Clinical Practice Cardiovascular Medicine, vol. 3, supplement 1, pp. S8–S13, 2006. View at Publisher · View at Google Scholar · View at PubMed
  60. M. Buckingham and D. Montarras, “Skeletal muscle stem cells,” Current Opinion in Genetics and Development, vol. 18, no. 4, pp. 330–336, 2008. View at Publisher · View at Google Scholar · View at PubMed
  61. P. Menasché, A. A. Hagège, M. Scorsin et al., “Myoblast transplantation for heart failure,” The Lancet, vol. 357, no. 9252, pp. 279–280, 2001. View at Publisher · View at Google Scholar · View at PubMed
  62. P. Menasché, A. A. Hagège, J. T. Vilquin et al., “Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction,” Journal of the American College of Cardiology, vol. 41, no. 7, pp. 1078–1083, 2003. View at Publisher · View at Google Scholar
  63. P. Menasché, “Skeletal myoblasts and cardiac repair,” Journal of Molecular and Cellular Cardiology, vol. 45, no. 4, pp. 545–553, 2008. View at Publisher · View at Google Scholar · View at PubMed
  64. P. Menasché, “Towards the second generation of skeletal myoblasts?” Cardiovascular Research, vol. 79, no. 3, pp. 355–356, 2008. View at Publisher · View at Google Scholar · View at PubMed
  65. M. Osawa, K. Nakamura, N. Nishi et al., “In vivo self-renewal of c-Kit+ Sca-1+ Lin (low/-) hemopoietic stem cells,” Journal of Immunology, vol. 156, no. 9, pp. 3207–3214, 1996.
  66. G. J. Spangrude, S. Heimfeld, and I. L. Weissman, “Purification and characterization of mouse hematopoietic stem cells,” Science, vol. 241, no. 4861, pp. 58–62, 1988.
  67. E. T. H. Yeh, S. Zhang, H. D. Wu, M. Körbling, J. T. Willerson, and Z. Estrov, “Transdifferentiation of human peripheral blood CD34-enriched cell population into cardiomyocytes, endothelial cells, and smooth muscle cells in vivo,” Circulation, vol. 108, no. 17, pp. 2070–2073, 2003. View at Publisher · View at Google Scholar · View at PubMed
  68. F. B. Bedada, A. Technau, H. Ebelt, M. Schulze, and T. Braun, “Activation of myogenic differentiation pathways in adult bone marrow-derived stem cells,” Molecular and Cellular Biology, vol. 25, no. 21, pp. 9509–9519, 2005. View at Publisher · View at Google Scholar · View at PubMed
  69. M. Koyanagi, P. Bushoven, M. Iwasaki, C. Urbich, A. M. Zeiher, and S. Dimmeler, “Notch signaling contributes to the expression of cardiac markers in human circulating progenitor cells,” Circulation Research, vol. 101, no. 11, pp. 1139–1145, 2007. View at Publisher · View at Google Scholar · View at PubMed
  70. M. P. Flaherty, A. Abdel-Latif, Q. Li et al., “Noncanonical Wnt11 signaling is sufficient to induce cardiomyogenic differentiation in unfractionated bone marrow mononuclear cells,” Circulation, vol. 117, no. 17, pp. 2241–2252, 2008. View at Publisher · View at Google Scholar · View at PubMed
  71. D. Orlic, J. Kajstura, S. Chimenti et al., “Bone marrow cells regenerate infarcted myocardium,” Nature, vol. 410, no. 6829, pp. 701–705, 2001. View at Publisher · View at Google Scholar · View at PubMed
  72. D. Orlic, J. Kajstura, S. Chimenti et al., “Mobilized bone marrow cells repair the infarcted heart, improving function and survival,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 18, pp. 10344–10349, 2001. View at Publisher · View at Google Scholar · View at PubMed
  73. J. Kajstura, M. Rota, B. Whang et al., “Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion,” Circulation Research, vol. 96, no. 1, pp. 127–137, 2005. View at Publisher · View at Google Scholar · View at PubMed
  74. M. Rota, J. Kajstura, T. Hosoda et al., “Bone marrow cells adopt the cardiomyogenic fate in vivo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 45, pp. 17783–17788, 2007. View at Publisher · View at Google Scholar · View at PubMed
  75. L. B. Balsam, A. J. Wagers, J. L. Christensen, T. Kofidis, I. L. Weissmann, and R. C. Robbins, “Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium,” Nature, vol. 428, no. 6983, pp. 668–673, 2004. View at Publisher · View at Google Scholar · View at PubMed
  76. C. E. Murry, M. H. Soonpaa, H. Reinecke et al., “Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts,” Nature, vol. 428, no. 6983, pp. 664–668, 2004. View at Publisher · View at Google Scholar · View at PubMed
  77. H. Kamihata, H. Matsubara, T. Nishiue et al., “Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines,” Circulation, vol. 104, no. 9, pp. 1046–1052, 2001.
  78. M. F. Pittenger, A. M. Mackay, S. C. Beck et al., “Multilineage potential of adult human mesenchymal stem cells,” Science, vol. 284, no. 5411, pp. 143–147, 1999. View at Publisher · View at Google Scholar
  79. Y. Jiang, B. N. Jahagirdar, R. L. Reinhardt et al., “Pluripotency of mesenchymal stem cells derived from adult marrow,” Nature, vol. 418, no. 6893, pp. 41–49, 2002. View at Publisher · View at Google Scholar · View at PubMed
  80. S. Makino, K. Fukuda, S. Miyoshi et al., “Cardiomyocytes can be generated from marrow stromal cells in vitro,” Journal of Clinical Investigation, vol. 103, no. 5, pp. 697–705, 1999.
  81. J.-Y. Min, M. F. Sullivan, Y. Yang et al., “Significant improvement of heart function by cotransplantation of human mesenchymal stem cells and fetal cardiomyocytes in postinfarcted pigs,” Annals of Thoracic Surgery, vol. 74, no. 5, pp. 1568–1575, 2002. View at Publisher · View at Google Scholar
  82. J. G. Shake, P. J. Gruber, W. A. Baumgartner et al., “Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects,” Annals of Thoracic Surgery, vol. 73, no. 6, pp. 1919–1926, 2002. View at Publisher · View at Google Scholar
  83. C. Toma, M. F. Pittenger, K. S. Cahill, B. J. Byrne, and P. D. Kessler, “Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart,” Circulation, vol. 105, no. 1, pp. 93–98, 2002. View at Publisher · View at Google Scholar
  84. C. A. Thompson, B. A. Nasseri, J. Makower et al., “Percutaneous transvenous cellular cardiomyoplasty: a novel nonsurgical approach for myocardial cell transplantation,” Journal of the American College of Cardiology, vol. 41, no. 11, pp. 1964–1971, 2003. View at Publisher · View at Google Scholar
  85. S. Rangappa, V. Reddy, A. Bongso, E. H. Lee, and E. K. W. Sim, “Transformation of the adult human mesenchymal stem cells into cardiomyocyte-like cells in vivo,” Cardiovascular Engineering, vol. 2, pp. 7–14, 2002.
  86. S. Gojo, N. Gojo, Y. Takeda et al., “In vivo cardiovasculogenesis by direct injection of isolated adult mesenchymal stem cells,” Experimental Cell Research, vol. 288, no. 1, pp. 51–59, 2003. View at Publisher · View at Google Scholar
  87. A. A. Mangi, N. Noiseux, D. Kong et al., “Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts,” Nature Medicine, vol. 9, no. 9, pp. 1195–1201, 2003. View at Publisher · View at Google Scholar · View at PubMed
  88. S. Davani, A. Marandin, N. Mersin et al., “Mesenchymal progenitor cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a rat cellular cardiomyoplasty model,” Circulation, vol. 108, no. 10, pp. II253–II258, 2003.
  89. L. C. Amado, A. P. Saliaris, K. H. Schuleri et al., “Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 32, pp. 11474–11479, 2005. View at Publisher · View at Google Scholar · View at PubMed
  90. S. Tomita, R. K. Li, R. D. Weisel et al., “Autologous transplantation of bone marrow cells improves damaged heart function,” Circulation, vol. 100, no. 19, pp. II247–II256, 1999.
  91. M. F. Pittenger and B. J. Martin, “Mesenchymal stem cells and their potential as cardiac therapeutics,” Circulation Research, vol. 95, no. 1, pp. 9–20, 2004. View at Publisher · View at Google Scholar · View at PubMed
  92. P. A. Zuk, M. Zhu, P. Ashjian et al., “Human adipose tissue is a source of multipotent stem cells,” Molecular Biology of the Cell, vol. 13, no. 12, pp. 4279–4295, 2002. View at Publisher · View at Google Scholar · View at PubMed
  93. M. J. Oedayrajsingh-Varma, S. M. van Ham, M. Knippenberg et al., “Adipose tissue-derived mesenchymal stem cell yield and growth characteristics are affected by the tissue-harvesting procedure,” Cytotherapy, vol. 8, no. 2, pp. 166–177, 2006. View at Publisher · View at Google Scholar · View at PubMed
  94. B. Prunet-Marcassus, B. Cousin, D. Caton, M. André, L. Pénicaud, and L. Casteilla, “From heterogeneity to plasticity in adipose tissues: site-specific differences,” Experimental Cell Research, vol. 312, no. 6, pp. 727–736, 2006. View at Publisher · View at Google Scholar · View at PubMed
  95. S. Hwangbo, J. Kim, S. Her, H. Cho, and J. Lee, “Therapeutic potential of human adipose stem cells in a rat myocardial infarction model,” Yonsei Medical Journal, vol. 51, no. 1, pp. 69–76, 2010. View at Publisher · View at Google Scholar · View at PubMed
  96. J. K. Fraser, I. Wulur, Z. Alfonso, and M. H. Hedrick, “Fat tissue: an underappreciated source of stem cells for biotechnology,” Trends in Biotechnology, vol. 24, no. 4, pp. 150–154, 2006. View at Publisher · View at Google Scholar · View at PubMed
  97. T. Asahara, T. Murohara, A. Sullivan et al., “Isolation of putative progenitor endothelial cells for angiogenesis,” Science, vol. 275, no. 5302, pp. 964–967, 1997. View at Publisher · View at Google Scholar
  98. U. M. Gehling, S. Ergün, U. Schumacher et al., “In vitro differentiation of endothelial cells from AC133-positive progenitor cells,” Blood, vol. 95, no. 10, pp. 3106–3112, 2000.
  99. M. Peichev, A. J. Naiyer, D. Pereira et al., “Expression of VEGFR-2 and AC133 by circulating human CD34 (+) cells identifies a population of functional endothelial precursors,” Blood, vol. 95, no. 3, pp. 952–958, 2000.
  100. Q. Shi, S. Rafii, M. H. Wu et al., “Evidence for circulating bone marrow-derived endothelial cells,” Blood, vol. 92, no. 2, pp. 362–367, 1998.
  101. P. P. Young, D. E. Vaughan, and A. K. Hatzopoulos, “Biologic properties of endothelial progenitor cells and their potential for cell therapy,” Progress in Cardiovascular Diseases, vol. 49, no. 6, pp. 421–429, 2007. View at Publisher · View at Google Scholar · View at PubMed
  102. D. A. Narmoneva, R. Vukmirovic, M. E. Davis, R. D. Kamm, and R. T. Lee, “Endothelial cells promote cardiac myocyte survival and spatial reorganization: implications for cardiac regeneration,” Circulation, vol. 110, no. 8, pp. 962–968, 2004. View at Publisher · View at Google Scholar · View at PubMed
  103. K. Jujo, M. Ii, and D. W. Losordo, “Endothelial progenitor cells in neovascularization of infarcted myocardium,” Journal of Molecular and Cellular Cardiology, vol. 45, no. 4, pp. 530–544, 2008. View at Publisher · View at Google Scholar · View at PubMed
  104. A. Kawamoto, T. Tkebuchava, J. I. Yamaguchi et al., “Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia,” Circulation, vol. 107, no. 3, pp. 461–468, 2003. View at Publisher · View at Google Scholar
  105. M. D. Schuster, A. A. Kocher, T. Seki et al., “Myocardial neovascularization by bone marrow angioblasts results in cardiomyocyte regeneration,” American Journal of Physiology, vol. 287, no. 2, pp. H525–H532, 2004. View at Publisher · View at Google Scholar · View at PubMed
  106. K. C. Wollert and H. Drexler, “Clinical applications of stem cells for the heart,” Circulation Research, vol. 96, no. 2, pp. 151–163, 2005. View at Publisher · View at Google Scholar · View at PubMed
  107. H. Mayani and P. M. Lansdorp, “Biology of human umbilical cord blood-derived hematopoietic stem/progenitor cells,” Stem Cells, vol. 16, no. 3, pp. 153–165, 1998.
  108. N. Ma, C. Stamm, A. Kaminski et al., “Human cord blood cells induce angiogenesis following myocardial infarction in NOD/scid-mice,” Cardiovascular Research, vol. 66, no. 1, pp. 45–54, 2005. View at Publisher · View at Google Scholar · View at PubMed
  109. Y. Hirata, M. Sata, N. Motomura et al., “Human umbilical cord blood cells improve cardiac function after myocardial infarction,” Biochemical and Biophysical Research Communications, vol. 327, no. 2, pp. 609–614, 2005. View at Publisher · View at Google Scholar · View at PubMed
  110. G. Kögler, S. Sensken, J. A. Airey et al., “A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential,” Journal of Experimental Medicine, vol. 200, no. 2, pp. 123–135, 2004. View at Publisher · View at Google Scholar · View at PubMed
  111. B.-O. Kim, H. Tian, K. Prasongsukarn et al., “Cell transplantation improves ventricular function after a myocardial infarction: a preclinical study of human unrestricted somatic stem cells in a porcine model,” Circulation, vol. 112, supplement 1, pp. I96–I104, 2005. View at Publisher · View at Google Scholar · View at PubMed
  112. R. A. Gatti, H. J. Meuwissen, H. D. Allen, R. Hong, and R. A. Good, “Immunological reconstitution of sex-linked lymphopenic immunological deficiency,” The Lancet, vol. 2, no. 7583, pp. 1366–1369, 1968.
  113. K. R. Chien, “Stem cells: lost in translation,” Nature, vol. 428, no. 6983, pp. 607–608, 2004. View at Publisher · View at Google Scholar · View at PubMed
  114. B. E. Strauer, M. Brehm, T. Zeus et al., “Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans,” Circulation, vol. 106, no. 15, pp. 1913–1918, 2002. View at Publisher · View at Google Scholar
  115. “Update on Clinical Trials in Cell Therapy for CV Disease,” http://www.clinialtrials.com.
  116. E. C. Perin and J. López, “Methods of stem cell delivery in cardiac diseases,” Nature Clinical Practice Cardiovascular Medicine, vol. 3, supplement 1, pp. S110–S113, 2006. View at Publisher · View at Google Scholar · View at PubMed
  117. B. Assmus, V. Schächinger, C. Teupe et al., “Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI),” Circulation, vol. 106, no. 24, pp. 3009–3017, 2002. View at Publisher · View at Google Scholar
  118. V. Schächinger, B. Assmus, M. B. Britten et al., “Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI trial,” Journal of the American College of Cardiology, vol. 44, no. 8, pp. 1690–1699, 2004. View at Publisher · View at Google Scholar · View at PubMed
  119. K. C. Wollert, G. P. Meyer, J. Lotz et al., “Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial,” The Lancet, vol. 364, no. 9429, pp. 141–148, 2004. View at Publisher · View at Google Scholar · View at PubMed
  120. F. Fernández-Avilés, J. A. San Román, J. García-Frade et al., “Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction,” Circulation Research, vol. 95, no. 7, pp. 742–748, 2004. View at Publisher · View at Google Scholar · View at PubMed
  121. V. K. Shah, A. J. Desai, J. B. Vasvani et al., “Bone marrow cells for myocardial repair—a new therapeutic concept,” Indian Heart Journal, vol. 59, no. 6, pp. 482–490, 2007.
  122. S. Janssens, C. Dubois, J. Bogaert et al., “Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial,” The Lancet, vol. 367, no. 9505, pp. 113–121, 2006. View at Publisher · View at Google Scholar · View at PubMed
  123. V. Schächinger, S. Erbs, A. Elsässer et al., “Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial,” European Heart Journal, vol. 27, no. 23, pp. 2775–2783, 2006. View at Publisher · View at Google Scholar · View at PubMed
  124. K. Lunde, S. Solheim, S. Aakhus et al., “Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction,” New England Journal of Medicine, vol. 355, no. 12, pp. 1199–1209, 2006. View at Publisher · View at Google Scholar · View at PubMed
  125. G. P. Meyer, K. C. Wollert, J. Lotz et al., “Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (Bone marrow transfer to enhance ST-elevation infarct regeneration) trial,” Circulation, vol. 113, no. 10, pp. 1287–1294, 2006. View at Publisher · View at Google Scholar · View at PubMed
  126. V. K. Shah, J. B. Vasvani, S. Payannavar, A. Walvalkar, and K. Shalia, “Stem cell therapy for acute myocardial infarction-long term 24 months follow-up: short title: follow-up of ABMSCs therapy in AMI,” Indin Heart Journal, vol. 59, p. 394, 2007.
  127. S. L. Chen, WU. W. Fang, F. Ye et al., “Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction,” American Journal of Cardiology, vol. 94, no. 1, pp. 92–95, 2004. View at Publisher · View at Google Scholar · View at PubMed
  128. P. R. Vulliet, M. Greeley, S. M. Halloran, K. A. MacDonald, and M. D. Kittleson, “Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs,” The Lancet, vol. 363, no. 9411, pp. 783–784, 2004. View at Publisher · View at Google Scholar · View at PubMed
  129. J. M. Hare, J. H. Traverse, T. D. Henry et al., “A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study of Intravenous Adult Human Mesenchymal Stem Cells (Prochymal) After Acute Myocardial Infarction,” Journal of the American College of Cardiology, vol. 54, no. 24, pp. 2277–2286, 2009. View at Publisher · View at Google Scholar · View at PubMed
  130. A. Abdel-Latif, R. Bolli, I. M. Tleyjeh et al., “Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis,” Archives of Internal Medicine, vol. 167, no. 10, pp. 989–997, 2007. View at Publisher · View at Google Scholar · View at PubMed
  131. N. Werner, S. Kosiol, T. Schiegl et al., “Circulating endothelial progenitor cells and cardiovascular outcomes,” New England Journal of Medicine, vol. 353, no. 10, pp. 999–1007, 2005. View at Publisher · View at Google Scholar · View at PubMed
  132. C. Stamm, H.-D. Kleine, Y.-H. Choi et al., “Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies,” Journal of Thoracic and Cardiovascular Surgery, vol. 133, no. 3, pp. 717–725.e5, 2007. View at Publisher · View at Google Scholar · View at PubMed
  133. D. W. Losordo, R. A. Schatz, C. J. White et al., “Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial,” Circulation, vol. 115, no. 25, pp. 3165–3172, 2007. View at Publisher · View at Google Scholar · View at PubMed
  134. J. Bartunek, M. Vanderheyden, B. Vandekerckhove et al., “Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety,” Circulation, vol. 112, no. 9, supplement, pp. I178–I183, 2005. View at Publisher · View at Google Scholar · View at PubMed
  135. S. Erbs, A. Linke, V. Adams et al., “Transplantation of blood-derived progenitor cells after recanalization of chronic coronary artery occlusion: first randomized and placebo-controlled study,” Circulation Research, vol. 97, no. 8, pp. 756–762, 2005. View at Publisher · View at Google Scholar · View at PubMed
  136. C. Stamm, B. Westphal, H. D. Kleine et al., “Autologous bone-marrow stem-cell transplantation for myocardial regeneration,” The Lancet, vol. 361, no. 9351, pp. 45–46, 2003. View at Publisher · View at Google Scholar · View at PubMed
  137. H. M. Klein, A. Ghodsizad, R. Marktanner et al., “Intramyocardial implantation of CD133+ stem cells improved cardiac function without bypass surgery.,” The Heart Surgery Forum, vol. 10, no. 1, pp. E66–E69, 2007. View at Publisher · View at Google Scholar · View at PubMed
  138. T. Lapidot and I. Petit, “Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells,” Experimental Hematology, vol. 30, no. 9, pp. 973–981, 2002. View at Publisher · View at Google Scholar
  139. A. M. Leone, S. Rutella, G. Bonanno et al., “Endogenous G-CSF and CD34+ cell mobilization after acute myocardial infarction,” International Journal of Cardiology, vol. 111, no. 2, pp. 202–208, 2006. View at Publisher · View at Google Scholar · View at PubMed
  140. O. Dewald, G. Ren, G. D. Duerr et al., “Of mice and dogs: species-specific differences in the inflammatory response following myocardial infarction,” American Journal of Pathology, vol. 164, no. 2, pp. 665–677, 2004.
  141. W. Wojakowski, M. Tendera, A. Michałowska et al., “Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction,” Circulation, vol. 110, no. 20, pp. 3213–3220, 2004. View at Publisher · View at Google Scholar · View at PubMed
  142. A. Namiki, E. Brogi, M. Kearney et al., “Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells,” Journal of Biological Chemistry, vol. 270, no. 52, pp. 31189–31195, 1995. View at Publisher · View at Google Scholar
  143. T. Couffinhal, M. Silver, LU. P. Zheng, M. Kearney, B. Witzenbichler, and J. M. Isner, “Mouse model of angiogenesis,” American Journal of Pathology, vol. 152, no. 6, pp. 1667–1679, 1998.
  144. S. Banai, M. T. Jaklitsch, M. Shou et al., “Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs,” Circulation, vol. 89, no. 5, pp. 2183–2189, 1994.
  145. Y. Wang, H. E. Johnsen, S. Mortensen et al., “Changes in circulating mesenchymal stem cells, stem cell homing factor, and vascular growth factors in patients with acute ST elevation myocardial infarction treated with primary percutaneous coronary intervention,” Heart, vol. 92, no. 6, pp. 768–774, 2006. View at Publisher · View at Google Scholar
  146. A. T. Askari, S. Unzek, Z. B. Popovic et al., “Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy,” The Lancet, vol. 362, no. 9385, pp. 697–703, 2003. View at Publisher · View at Google Scholar · View at PubMed
  147. C. Vogt, G. Noe, and I. N. Rich, “The role of the blood island during normal and 5-fluorouracil-perturbated hemopoiesis,” Blood Cells, vol. 17, no. 1, pp. 105–121, 1991.
  148. C. Heeschen, A. Aicher, R. Lehmann et al., “Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization,” Blood, vol. 102, no. 4, pp. 1340–1346, 2003. View at Publisher · View at Google Scholar · View at PubMed
  149. C. Kalka, H. Masuda, T. Takahashi et al., “Vascular endothelial growth factor gene transfer augments circulating endothelial progenitor cells in human subjects,” Circulation Research, vol. 86, no. 12, pp. 1198–1202, 2000.
  150. J. Llevadot, S. Murasawa, Y. Kureishi et al., “HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells,” Journal of Clinical Investigation, vol. 108, no. 3, pp. 399–405, 2001. View at Publisher · View at Google Scholar
  151. D. H. Walter, K. Rittig, F. H. Bahlmann et al., “Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells,” Circulation, vol. 105, no. 25, pp. 3017–3024, 2002. View at Publisher · View at Google Scholar
  152. H. Ince, M. Petzsch, H. D. Kleine et al., “Prevention of left ventricular remodeling with granulocyte colony-stimulating factor after acute myocardial infarction: final 1-year results of the front-integrated revascularization and stem cell liberation in evolving acute myocardial infarction by granulocyte colony-stimulating factor (FIRSTLINE-AMI) trial,” Circulation, vol. 112, no. 9, supplement, pp. I73–I80, 2005. View at Publisher · View at Google Scholar · View at PubMed
  153. R. S. Ripa, E. Jørgensen, Y. Wang et al., “Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial,” Circulation, vol. 113, no. 16, pp. 1983–1992, 2006. View at Publisher · View at Google Scholar · View at PubMed
  154. D. Zohlnhöfer, I. Ott, J. Mehilli et al., “Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial,” Journal of the American Medical Association, vol. 295, no. 9, pp. 1003–1010, 2006. View at Publisher · View at Google Scholar · View at PubMed
  155. M. G. Engelmann, H. D. Theiss, C. Hennig-Theiss et al., “Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial,” Journal of the American College of Cardiology, vol. 48, no. 8, pp. 1712–1721, 2006. View at Publisher · View at Google Scholar · View at PubMed
  156. A. Abdel-Latif, R. Bolli, E. K. Zuba-Surma, I. M. Tleyjeh, C. A. Hornung, and B. Dawn, “Granulocyte colony-stimulating factor therapy for cardiac repair after acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials,” American Heart Journal, vol. 156, no. 2, pp. 216–226.e9, 2008. View at Publisher · View at Google Scholar · View at PubMed
  157. J. S. Silvestre, A. Gojova, V. Brun et al., “Transplantation of bone marrow-derived mononuclear cells in ischemic apolipoprotein E-knockout mice accelerates atherosclerosis without altering plaque composition,” Circulation, vol. 108, no. 23, pp. 2839–2842, 2003. View at Publisher · View at Google Scholar · View at PubMed
  158. S. Mansour, M. Vanderheyden, B. De Bruyne et al., “Intracoronary delivery of hematopoietic bone marrow stem cells and luminal loss of the infarct-related artery in patients with recent myocardial infarction,” Journal of the American College of Cardiology, vol. 47, no. 8, pp. 1727–1730, 2006. View at Publisher · View at Google Scholar · View at PubMed
  159. B. Assmus, D. H. Walter, R. Lehmann et al., “Intracoronary infusion of progenitor cells is not associated with aggravated restenosis development or atherosclerotic disease progression in patients with acute myocardial infarction,” European Heart Journal, vol. 27, no. 24, pp. 2989–2995, 2006. View at Publisher · View at Google Scholar · View at PubMed
  160. Y. S. Yoon, J. S. Park, T. Tkebuchava, C. Luedeman, and D. W. Losordo, “Unexpected severe calcification after transplantation of bone marrow cells in acute myocardial infarction,” Circulation, vol. 109, no. 25, pp. 3154–3157, 2004.
  161. M. Breitbach, T. Bostani, W. Roell et al., “Potential risks of bone marrow cell transplantation into infarcted hearts,” Blood, vol. 110, no. 4, pp. 1362–1369, 2007. View at Publisher · View at Google Scholar · View at PubMed
  162. C. E. Murry, H. Reinecke, and L. M. Pabon, “Regeneration gap: observation on stem cell and cardiac repair,” Journal of the American College of Cardiology, vol. 47, no. 9, pp. 1777–1785, 2006. View at Publisher · View at Google Scholar · View at PubMed
  163. C. E. Murry, L. J. Field, and P. Menasché, “Cell-based cardiac repair reflections at the 10-year point,” Circulation, vol. 112, no. 20, pp. 3174–3183, 2005. View at Publisher · View at Google Scholar · View at PubMed
  164. T. Kinnaird, E. Stabile, M. S. Burnett et al., “Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms,” Circulation Research, vol. 94, no. 5, pp. 678–685, 2004. View at Publisher · View at Google Scholar · View at PubMed
  165. M. Gnecchi, H. He, N. Noiseux et al., “Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement,” FASEB Journal, vol. 20, no. 6, pp. 661–669, 2006. View at Publisher · View at Google Scholar · View at PubMed
  166. B. Kühn, F. Del Monte, R. J. Hajjar et al., “Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair,” Nature Medicine, vol. 13, no. 8, pp. 962–969, 2007. View at Publisher · View at Google Scholar · View at PubMed
  167. R. Uemura, M. Xu, N. Ahmad, and M. Ashraf, “Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling,” Circulation Research, vol. 98, no. 11, pp. 1414–1421, 2006. View at Publisher · View at Google Scholar · View at PubMed
  168. C. Urbich, A. Aicher, C. Heeschen et al., “Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells,” Journal of Molecular and Cellular Cardiology, vol. 39, no. 5, pp. 733–742, 2005. View at Publisher · View at Google Scholar · View at PubMed
  169. M. Xu, R. Uemura, Y. Dai, Y. Wang, Z. Pasha, and M. Ashraf, “In vitro and in vivo effects of bone marrow stem cells on cardiac structure and function,” Journal of Molecular and Cellular Cardiology, vol. 42, no. 2, pp. 441–448, 2007. View at Publisher · View at Google Scholar · View at PubMed
  170. R. Hinkel, C. El-Aouni, T. Olson et al., “Thymosin β4 is an essential paracrine factor of embryonic endothelial progenitor cell-mediated cardioprotection,” Circulation, vol. 117, no. 17, pp. 2232–2240, 2008. View at Publisher · View at Google Scholar · View at PubMed
  171. M. Mirotsou, Z. Zhang, A. Deb et al., “Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 5, pp. 1643–1648, 2007. View at Publisher · View at Google Scholar · View at PubMed
  172. M. P. Alfaro, M. Pagnia, A. Vincent et al., “The Wnt modulator sFRP2 enhances mesenchymal stem cell engraftment, granulation tissue formation and myocardial repair,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 47, pp. 18366–18371, 2008. View at Publisher · View at Google Scholar · View at PubMed
  173. C. Kupatt, R. Kinkel, M. Lamparter et al., “Retroinfusion of embryonic endothelial progenitor cells attenuates ischemia-reperfusion injury in pigs: role of phosphatidylinositol 3-kinase/AKT kinase,” Circulation, vol. 112, no. 9, supplement, pp. I117–I122, 2005. View at Publisher · View at Google Scholar · View at PubMed
  174. C. Kupatt, J. Horstkotte, G. A. Vlastos et al., “Embryonic endothelial progenitor cells expressing a broad range of proangiogenic and remodeling factors enhance vascularization and tissue recovery in acute and chronic ischemia,” FASEB Journal, vol. 19, no. 11, pp. 1576–1578, 2005. View at Publisher · View at Google Scholar · View at PubMed
  175. M. Heil, T. Ziegelhoeffer, B. Mees, and W. Schaper, “A different outlook on the role of bone marrow stem cells in vascular growth, bone marrow delivers the software not hardware,” Circulation Research, vol. 94, no. 5, pp. 573–574, 2004. View at Publisher · View at Google Scholar · View at PubMed
  176. H. K. Haider, S. Jiang, N. M. Idris, and M. Ashraf, “IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1α/CXCR4 signaling to promote myocardial repair,” Circulation Research, vol. 103, no. 11, pp. 1300–1308, 2008. View at Publisher · View at Google Scholar · View at PubMed
  177. G. Olivetti, J. M. Capasso, E. H. Sonnenblick, and P. Anversa, “Side-to-side slippage of myocytes participates in ventricular wall remodeling acutely after myocardial infarction in rats,” Circulation Research, vol. 67, no. 1, pp. 23–34, 1990.
  178. J. B. Caulfield, R. Leinbach, and H. Gold, “The relationship of myocardial infarct size and prognosis,” Circulation, vol. 53, no. 3, pp. I141–I144, 1976.
  179. N. G. Frangogiannis, C. W. Smith, and M. L. Entman, “The inflammatory response in myocardial infarction,” Cardiovascular Research, vol. 53, no. 1, pp. 31–47, 2002. View at Publisher · View at Google Scholar
  180. M. Allgöwer, The Cellular Basis of Wound Repair, Charles C. Thomas, Springfield, Ill, USA, 1956.
  181. Y. Xie, T. Zhou, W. Shen, G. Lu, T. Yin, and L. Gong, “Soluble cell adhesion molecules in patients with acute coronary syndrome,” Chinese Medical Journal, vol. 113, no. 3, pp. 286–288, 2000.
  182. T. Soeki, Y. Tamura, H. Shinohara, H. Tanaka, K. Bando, and N. Fukuda, “Serial changes in serum VEGF and HGF in patients with acute myocardial infarction,” Cardiology, vol. 93, no. 3, pp. 168–174, 2000.
  183. H. M. Wei, P. Wong, L. F. Hsu, and W. Shim, “Human bone marrow-derived adult stem cells for post-myocardial infarction cardiac repair: current status and future directions,” Singapore Medical Journal, vol. 50, no. 10, pp. 935–942, 2009.
  184. F. H. Seeger, T. Tonn, N. Krzossok, A. M. Zeiher, and S. Dimmeler, “Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction,” European Heart Journal, vol. 28, no. 6, pp. 766–772, 2007. View at Publisher · View at Google Scholar · View at PubMed
  185. E. C. Perin, H. F.R. Dohmann, R. Borojevic et al., “Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure,” Circulation, vol. 107, no. 18, pp. 2294–2302, 2003. View at Publisher · View at Google Scholar · View at PubMed
  186. J. Herrerosa, F. Prósper, A. Perez et al., “Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction,” European Heart Journal, vol. 24, no. 22, pp. 2012–2020, 2003. View at Publisher · View at Google Scholar
  187. J. M. Hill, A. J. Dick, V. K. Raman et al., “Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells,” Circulation, vol. 108, no. 8, pp. 1009–1014, 2003. View at Publisher · View at Google Scholar · View at PubMed
  188. M. Hofmann, K. C. Wollert, G. P. Meyer et al., “Monitoring of bone marrow cell homing into the infarcted human myocardium,” Circulation, vol. 111, no. 17, pp. 2198–2202, 2005. View at Publisher · View at Google Scholar · View at PubMed
  189. J. C. Wu, I. Y. Chen, G. Sundaresan et al., “Molecular imaging of cardiac cell transplantation in living animals using optical bioluminescence and positron emission tomography,” Circulation, vol. 108, no. 11, pp. 1302–1305, 2003. View at Publisher · View at Google Scholar · View at PubMed
  190. F. D. Pagani, H. DerSimonian, A. Zawadzka et al., “Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans: histological analysis of cell survival and differentiation,” Journal of the American College of Cardiology, vol. 41, no. 5, pp. 879–888, 2003. View at Publisher · View at Google Scholar
  191. A. A. Hagège, C. Carrion, P. Menasché et al., “Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy,” The Lancet, vol. 361, no. 9356, pp. 491–492, 2003. View at Publisher · View at Google Scholar · View at PubMed
  192. Steering Committee of the National Heart L, “Blood Institute Cardiovascular Cell Therapy Research Network. Cardiac cell therapy: bench or bedside?” Nature Clinical Practice Cardiovascular Medicine, vol. 4, p. 403, 2007.
  193. V. J. Dzau, M. Gnecchi, and A. S. Pachori, “Enhancing stem cell therapy through genetic modification,” Journal of the American College of Cardiology, vol. 46, no. 7, pp. 1351–1353, 2005. View at Publisher · View at Google Scholar · View at PubMed
  194. X. Liu, A. S. Pachori, C. A. Ward et al., “Heme oxygenase-1 (HO-1) inhibits postmyocardial infarct remodeling and restores ventricular function,” FASEB Journal, vol. 20, no. 2, pp. 207–216, 2006. View at Publisher · View at Google Scholar · View at PubMed
  195. H. K. Haider, S. Jiang, N. M. Idris, and M. Ashraf, “IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1α/CXCR4 signaling to promote myocardial repair,” Circulation Research, vol. 103, no. 11, pp. 1300–1308, 2008. View at Publisher · View at Google Scholar · View at PubMed
  196. A. A. Mangi, N. Noiseux, D. Kong et al., “Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts,” Nature Medicine, vol. 9, no. 9, pp. 1195–1201, 2003. View at Publisher · View at Google Scholar · View at PubMed
  197. R. Sanz-Ruiz, E. Gutiérrez Ibañes, A. V. Arranz, M. E. Fernández Santos, P. L. Fernández, and F. Fernández-Avilés, “Phases I-III clinical trials using adult stem cells,” Stem Cells International, vol. 2010, Article ID 579142, 2010.
  198. J. Yu, M. A. Vodyanik, K. Smuga-Otto et al., “Induced pluripotent stem cell lines derived from human somatic cells,” Science, vol. 318, no. 5858, pp. 1917–1920, 2007. View at Publisher · View at Google Scholar · View at PubMed
  199. H. C. Ott, T. S. Matthiesen, S. K. Goh et al., “Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart,” Nature Medicine, vol. 14, no. 2, pp. 213–221, 2008. View at Publisher · View at Google Scholar · View at PubMed
  200. G. Narazaki, H. Uosaki, M. Teranishi et al., “Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells,” Circulation, vol. 118, no. 5, pp. 498–506, 2008. View at Publisher · View at Google Scholar · View at PubMed
  201. O. Capi and L. Gepstein, “Myocardial regeneration strategies using human embryonic stem cell-derived cardiomyocytes,” Journal of Controlled Release, vol. 116, no. 2, pp. 211–218, 2006. View at Publisher · View at Google Scholar · View at PubMed
  202. I. Kehat, L. Khimovich, O. Caspi et al., “Electromechanical integration of cardiomyocytes derived from human embryonic stem cells,” Nature Biotechnology, vol. 22, no. 10, pp. 1282–1289, 2004. View at Publisher · View at Google Scholar · View at PubMed
  203. M. A. Laflamme, K. Y. Chen, A. V. Naumova et al., “Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts,” Nature Biotechnology, vol. 25, no. 9, pp. 1015–1024, 2007. View at Publisher · View at Google Scholar · View at PubMed
  204. J. Y. Hahn, H. J. Cho, H. J. Kang et al., “Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction,” Journal of the American College of Cardiology, vol. 51, no. 9, pp. 933–943, 2008. View at Publisher · View at Google Scholar · View at PubMed
  205. T.-S. Li, M. Hayashi, H. Ito et al., “Regeneration of infarcted myocardium by intramyocardial implantation of ex vivo transforming growth factor-β-preprogrammed bone marrow stem cells,” Circulation, vol. 111, no. 19, pp. 2438–2445, 2005. View at Publisher · View at Google Scholar · View at PubMed
  206. G. Q. Daley and D. T. Scadden, “Prospects for stem cell-based therapy,” Cell, vol. 132, no. 4, pp. 544–548, 2008. View at Publisher · View at Google Scholar · View at PubMed
  207. R. M. Lewis, D. J. Gordon, P. A. Poole-Wilson, J. S. Borer, and F. Zannad, “Similarities and differences in design considerations for cell therapy and pharmacologic cardiovascular clinical trials,” Cardiology, vol. 110, no. 2, pp. 73–80, 2008. View at Publisher · View at Google Scholar · View at PubMed
  208. J. F. Martin, “Stem cells and the heart: ethics, organization and funding,” Nature Clinical Practice Cardiovascular Medicine, vol. 3, supplement 1, pp. S136–S137, 2006. View at Publisher · View at Google Scholar · View at PubMed
  209. M. Camilleri, G. L. Gamble, S. L. Kopecky, M. B. Wood, and M. L. Hockema, “Principles and process in the development of the Mayo Clinic's individual and institutional conflict of interest policy,” Mayo Clinic Proceedings, vol. 80, no. 10, pp. 1340–1346, 2005.
  210. B. Lo, A. Kriegstein, and D. Grady, “Clinical trials in stem cell transplantation: guidelines for scientific and ethical review,” Clinical Trials, vol. 5, no. 5, pp. 517–522, 2008. View at Publisher · View at Google Scholar · View at PubMed
  211. R. Yim, “Administrative and research policies required to bring cellular therapies from the research laboratory to the patient's bedside,” Transfusion, vol. 45, no. 4, supplement, pp. 144S–158S, 2005. View at Publisher · View at Google Scholar · View at PubMed
  212. J. Bartunek, S. Dimmeler, H. Drexler et al., “The consensus of the task force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for repair of the heart,” European Heart Journal, vol. 27, no. 11, pp. 1338–1340, 2006. View at Publisher · View at Google Scholar · View at PubMed